Thomas D. Madden
23Patents
17h-index
45Co-inventors
81Inventor score
Filing activity: Jul 26, 1985 → Oct 26, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5885613A | Bilayer stabilizing components and their use in forming programmable fusogenic liposomes | Emerging Cross-Sectional Technologies | 250 | Expired |
| US5077056A | Encapsulation of antineoplastic agents in liposomes | Emerging Cross-Sectional Technologies | 204 | Expired |
| US4880635A | Dehydrated liposomes | Human Necessities | 199 | Expired |
| US5820873A | Polyethylene glycol modified ceramide lipids and liposome uses thereof | Emerging Cross-Sectional Technologies | 150 | Expired |
| US5736155A | Encapsulation of antineoplastic agents in liposomes | Human Necessities | 101 | Expired |
| US9139554B2 | Amino lipids and methods for the delivery of nucleic acids | Emerging Cross-Sectional Technologies | 72 | Active |
| US7811602B2 | Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof | Human Necessities | 64 | Active |
| US6406713B1 | Methods of preparing low-toxicity drug-lipid complexes | Emerging Cross-Sectional Technologies | 64 | Expired |
| US5922350A | Methods of dehydrating, storing and rehydrating liposomes | Human Necessities | 59 | Expired |
| US6986902B1 | Polyanionic polymers which enhance fusogenicity | Chemistry; Metallurgy | 58 | Expired |
| US5616334A | Low toxicity drug-lipid systems | Emerging Cross-Sectional Technologies | 58 | Expired |
| US5578320A | Method of dehydrating liposomes using protective sugars | Human Necessities | 46 | Expired |
| US5837279A | Encapsulation of ionizable agents in liposomes | Human Necessities | 38 | Expired |
| US5858397A | Liposomal formulations of mitoxantrone | Human Necessities | 33 | Expired |
| US7060828B2 | Liposomal camptothecins and uses thereof | Human Necessities | 28 | Expired |
| US10653780B2 | Amino lipids and methods for the delivery of nucleic acids | Emerging Cross-Sectional Technologies | 18 | Active |
| US5389378A | Benzoporphyrin vesicles and their use in photodynamic therapy | Emerging Cross-Sectional Technologies | 17 | Expired |
| US4963297A | Spontaneous vesticulation of multilamellar liposomes | Emerging Cross-Sectional Technologies | 15 | Expired |
| US7244448B2 | Liposomal antineoplastic drugs and uses thereof | Human Necessities | 13 | Expired |
| US6673364B1 | Liposome having an exchangeable component | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7311924B2 | Compositions and methods for treating cancer | Human Necessities | 5 | Expired |
| US7452550B2 | Liposomal antineoplastic drugs and uses thereof | Human Necessities | 4 | Expired |
| US11712481B2 | Lipid nanoparticle formulations | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.